Eurofins Scientific SE (ERFSF)
USD 49.72
(0.0%)
USD 49.72
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 947.3 Million | 1.13 Billion | 1.5 Billion | 1.22 Billion | 677.9 Million | 543.89 Million |
| Net Income | 310.3 Million | 780 Million | 1.05 Billion | 694.4 Million | 271.5 Million | 289.84 Million |
| Depreciation & Amortization | 664.3 Million | 504.4 Million | 450.7 Million | 426 Million | 395.9 Million | 223.74 Million |
| Deferred income taxes | -1.51 Billion | - | -298.9 Million | -95.8 Million | -95.6 Million | -68.2 Million |
| Stock-based compensation | 137.7 Million | 136.1 Million | 131 Million | 124.5 Million | 70.5 Million | 83.73 Million |
| Change in working capital | -64.8 Million | 33 Million | -6.6 Million | -29.7 Million | -56.8 Million | -21.44 Million |
| Other non-cash items | 1.41 Billion | -317.2 Million | 176.9 Million | 104.1 Million | 92.4 Million | 36.22 Million |
| Investing Cash Flow | -692.7 Million | -855.9 Million | -1.03 Billion | -525 Million | -540.2 Million | -1.55 Billion |
| Investments in PPE | -550.1 Million | -660.2 Million | -519.5 Million | -355.5 Million | -425.1 Million | -364.44 Million |
| Acquisitions | -144.4 Million | -214.7 Million | -532.7 Million | -177.2 Million | -171 Million | -1.25 Billion |
| Investment purchases | - | -1.5 Million | -8.4 Million | -100 Thousand | -47.6 Million | -53.87 Million |
| Sales/Maturities of investments | 1.9 Million | 1.5 Million | 8.4 Million | 100 Thousand | 47.6 Million | 53.87 Million |
| Other Investing Activities | -100 Thousand | 19 Million | 18 Million | 7.7 Million | 55.9 Million | 61.25 Million |
| Financing Cash Flow | 495.8 Million | -311.3 Million | -910.3 Million | -48.6 Million | -342.2 Million | 691.06 Million |
| Debt repayment | -548.5 Million | -82.9 Million | -453.6 Million | -1.3 Billion | -445 Million | -366.98 Million |
| Dividends payments | -191.9 Million | -192.1 Million | -129.69 Million | -300 Thousand | -51.2 Million | -42.64 Million |
| Common Stock Repurchased | -55.8 Million | -15.8 Million | -3.6 Million | 727.8 Million | -300 Million | 1.12 Billion |
| Common Stock Issuance | 601.5 Million | 14.6 Million | 35.8 Million | 564.8 Million | 321 Million | 20.04 Million |
| Other Financing Activities | 690.5 Million | -34.7 Million | -358.5 Million | -36.2 Million | 133.2 Million | -48.72 Million |
| Accounts receivables | -20 Million | -9 Million | -109.6 Million | 131.5 Million | -145.7 Million | -166.96 Million |
| Accounts payables | -41.4 Million | 20.1 Million | 85.6 Million | 132.19 Million | 36.8 Million | 71.14 Million |
| Inventory | 11 Million | 8.6 Million | 2.8 Million | -77.7 Million | -12.9 Million | -14.56 Million |
| Other working capital | -14.4 Million | 13.3 Million | 14.6 Million | -215.69 Million | 65 Million | 88.94 Million |
| Cash at beginning of period | 432.2 Million | 515 Million | 910.5 Million | 294.5 Million | 495 Million | 816.02 Million |
| Cash at end of period | 749.1 Million | 483.2 Million | 515 Million | 910.5 Million | 294.5 Million | 495 Million |
| Capital Expenditure | -550.1 Million | -660.2 Million | -519.5 Million | -355.5 Million | -425.1 Million | -364.44 Million |
| Effect of forex changes on cash | -12.7 Million | -800 Thousand | 39.1 Million | -33.9 Million | 4.1 Million | 1.46 Million |
| Net cash flow / Change in cash | 316.9 Million | -31.8 Million | -395.5 Million | 616 Million | -200.5 Million | -321.02 Million |
| Free Cash Flow | 397.2 Million | 476.1 Million | 990.3 Million | 868 Million | 252.8 Million | 179.44 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 220.7 Million | 310.3 Million | 158.8 Million | 151.5 Million | 780 Million | 300.5 Million |
| Depreciation & Amortization | 331.8 Million | 664.3 Million | 353.6 Million | 310.7 Million | 504.4 Million | 312.8 Million |
| Deferred income taxes | - | -1.51 Billion | - | -681.6 Million | - | -675.1 Million |
| Stock-based compensation | 57.6 Million | 137.7 Million | 62.4 Million | 60.2 Million | 136.1 Million | 66.8 Million |
| Change in working capital | -77.7 Million | -64.8 Million | 89.5 Million | -154.3 Million | 33 Million | 134.3 Million |
| Other non-cash items | -2.1 Million | 1.41 Billion | 732.7 Million | 633.4 Million | -317.2 Million | 512.7 Million |
| Investing Cash Flow | -483.9 Million | -692.7 Million | -358.6 Million | -334.1 Million | -855.9 Million | -382.8 Million |
| Investments in PPE | -217.5 Million | -550.1 Million | -287.4 Million | -262.7 Million | -660.2 Million | -370.6 Million |
| Acquisitions | -246.5 Million | -144.4 Million | -73.1 Million | -71.3 Million | -214.7 Million | -14.9 Million |
| Investment purchases | -1.2 Million | - | 100 Thousand | -100 Thousand | -1.5 Million | 1.2 Million |
| Sales/Maturities of investments | - | 1.9 Million | 1.9 Million | 100.6 Million | 1.5 Million | 1.5 Million |
| Other Investing Activities | -19.9 Million | -100 Thousand | -100 Thousand | -17.2 Million | 19 Million | 178.6 Million |
| Financing Cash Flow | -588.1 Million | 495.8 Million | 272.2 Million | 223.6 Million | -311.3 Million | -444.6 Million |
| Debt repayment | -526.6 Million | -548.5 Million | -612.8 Million | -64.3 Million | -82.9 Million | -270.2 Million |
| Dividends payments | -1 Million | -191.9 Million | -191.9 Million | -8.9 Million | -192.1 Million | -192.1 Million |
| Common Stock Repurchased | -29.6 Million | -55.8 Million | -19 Million | -36.8 Million | -15.8 Million | -7.7 Million |
| Common Stock Issuance | - | 601.5 Million | -400 Thousand | 601.9 Million | 14.6 Million | 6.8 Million |
| Other Financing Activities | -31.9 Million | 690.5 Million | -33.7 Million | -192.3 Million | -34.7 Million | -433.5 Million |
| Accounts receivables | - | -20 Million | -43.4 Million | - | -9 Million | 79.9 Million |
| Accounts payables | - | -41.4 Million | - | - | 20.1 Million | - |
| Inventory | - | 11 Million | 11 Million | - | 8.6 Million | 16 Million |
| Other working capital | -77.7 Million | -14.4 Million | 153 Million | -154.3 Million | 13.3 Million | 29.4 Million |
| Cash at beginning of period | 749.1 Million | 432.2 Million | 686.4 Million | 432.2 Million | 515 Million | 718.8 Million |
| Cash at end of period | 680.6 Million | 749.1 Million | 749.1 Million | 686.4 Million | 483.2 Million | 432.2 Million |
| Capital Expenditure | -217.5 Million | -550.1 Million | -287.4 Million | -262.7 Million | -660.2 Million | -370.6 Million |
| Effect of forex changes on cash | 1.2 Million | -12.7 Million | -1.6 Million | -11.1 Million | -800 Thousand | -10.8 Million |
| Net cash flow / Change in cash | -68.5 Million | 316.9 Million | 62.7 Million | 254.2 Million | -31.8 Million | -286.6 Million |
| Free Cash Flow | 312.79 Million | 397.2 Million | 340 Million | 57.2 Million | 476.1 Million | 264.1 Million |
CEUMF
RR
CFX
WBNEF
EMAMIPAP
1412